Pediatrix Medical Group (NYSE:MD) Shares Up 4.9% - Time to Buy?

Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report)'s share price rose 4.9% during trading on Tuesday . The company traded as high as $14.67 and last traded at $14.66. Approximately 209,974 shares traded hands during trading, a decline of 54% from the average daily volume of 455,716 shares. The stock had previously closed at $13.98.

Wall Street Analyst Weigh In

MD has been the subject of a number of recent research reports. Truist Financial reduced their price objective on shares of Pediatrix Medical Group from $16.00 to $15.00 and set a "hold" rating for the company in a research note on Monday, January 6th. Macquarie assumed coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They issued an "outperform" rating and a $18.00 target price on the stock. Jefferies Financial Group upped their target price on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the company a "buy" rating in a report on Tuesday, November 5th. UBS Group upped their target price on shares of Pediatrix Medical Group from $10.50 to $16.50 and gave the company a "neutral" rating in a report on Tuesday, November 5th. Finally, Mizuho upped their target price on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the company a "neutral" rating in a report on Tuesday, November 19th. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, Pediatrix Medical Group has an average rating of "Hold" and an average price target of $16.25.

Pediatrix Medical Group Stock Performance

The company's fifty day simple moving average is $13.81 and its two-hundred day simple moving average is $12.75. The stock has a market capitalization of $1.21 billion, a P/E ratio of -4.60, a PEG ratio of 1.38 and a beta of 1.57. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.42 and a current ratio of 1.42.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. increased its holdings in shares of Pediatrix Medical Group by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 10,812,611 shares of the company's stock worth $141,861,000 after purchasing an additional 113,976 shares during the period. Rubric Capital Management LP increased its holdings in shares of Pediatrix Medical Group by 1.5% during the third quarter. Rubric Capital Management LP now owns 8,275,000 shares of the company's stock worth $95,907,000 after purchasing an additional 125,000 shares during the period. State Street Corp boosted its position in shares of Pediatrix Medical Group by 1.4% during the 3rd quarter. State Street Corp now owns 3,540,791 shares of the company's stock worth $41,038,000 after acquiring an additional 50,597 shares in the last quarter. Pacer Advisors Inc. acquired a new stake in shares of Pediatrix Medical Group during the 4th quarter worth approximately $35,492,000. Finally, Boston Partners boosted its position in shares of Pediatrix Medical Group by 25.2% during the 4th quarter. Boston Partners now owns 1,956,353 shares of the company's stock worth $25,922,000 after acquiring an additional 393,600 shares in the last quarter. 97.71% of the stock is owned by institutional investors.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.